173 related articles for article (PubMed ID: 31349439)
1. Hydrogel implants for transscleral drug delivery for retinoblastoma treatment.
Cocarta AI; Hobzova R; Sirc J; Cerna T; Hrabeta J; Svojgr K; Pochop P; Kodetova M; Jedelska J; Bakowsky U; Uhlik J
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109799. PubMed ID: 31349439
[TBL] [Abstract][Full Text] [Related]
2. Hydrogel implants for transscleral diffusion delivery of topotecan: In vivo proof of concept in a rabbit eye model.
Hobzova R; Kodetova M; Pochop P; Uhlik J; Dunovska K; Svojgr K; Hrabeta J; Feriancikova B; Cocarta AI; Sirc J
Int J Pharm; 2021 Sep; 606():120832. PubMed ID: 34175379
[TBL] [Abstract][Full Text] [Related]
3. Sustained-release hydrogels of topotecan for retinoblastoma.
Taich P; Moretton MA; Del Sole MJ; Winter U; Bernabeu E; Croxatto JO; Oppezzo J; Williams G; Chantada GL; Chiappetta DA; Schaiquevich P
Colloids Surf B Biointerfaces; 2016 Oct; 146():624-31. PubMed ID: 27429296
[TBL] [Abstract][Full Text] [Related]
4. Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
Laurie NA; Gray JK; Zhang J; Leggas M; Relling M; Egorin M; Stewart C; Dyer MA
Clin Cancer Res; 2005 Oct; 11(20):7569-78. PubMed ID: 16243833
[TBL] [Abstract][Full Text] [Related]
5. Hydrogel probe for iontophoresis drug delivery to the eye.
Eljarrat-Binstock E; Raiskup F; Frucht-Pery J; Domb AJ
J Biomater Sci Polym Ed; 2004; 15(4):397-413. PubMed ID: 15212325
[TBL] [Abstract][Full Text] [Related]
6. The Role of Cryotherapy in Vitreous Concentrations of Topotecan Delivered by Episcleral Hydrogel Implant.
Kodetova M; Hobzova R; Sirc J; Uhlik J; Dunovska K; Svojgr K; Cocarta AI; Felsoova A; Slanar O; Sima M; Kozak I; Pochop P
Pharmaceutics; 2022 Apr; 14(5):. PubMed ID: 35631489
[TBL] [Abstract][Full Text] [Related]
7. Sustained release of active chemotherapeutics from injectable-solid β-hairpin peptide hydrogel.
Sun JE; Stewart B; Litan A; Lee SJ; Schneider JP; Langhans SA; Pochan DJ
Biomater Sci; 2016 May; 4(5):839-48. PubMed ID: 26906463
[TBL] [Abstract][Full Text] [Related]
8. Green Light-Triggered Intraocular Drug Release for Intravenous Chemotherapy of Retinoblastoma.
Long K; Yang Y; Lv W; Jiang K; Li Y; Lo ACY; Lam WC; Zhan C; Wang W
Adv Sci (Weinh); 2021 Oct; 8(20):e2101754. PubMed ID: 34448360
[TBL] [Abstract][Full Text] [Related]
9. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.
Schver GCRM; Lee PI
Mol Pharm; 2018 May; 15(5):2017-2026. PubMed ID: 29601723
[TBL] [Abstract][Full Text] [Related]
10. Drug loading optimization and extended drug delivery of corticoids from pHEMA based soft contact lenses hydrogels via chemical and microstructural modifications.
García-Millán E; Koprivnik S; Otero-Espinar FJ
Int J Pharm; 2015 Jun; 487(1-2):260-9. PubMed ID: 25891253
[TBL] [Abstract][Full Text] [Related]
11. Controlling methacryloyl substitution of chondroitin sulfate: injectable hydrogels with tunable long-term drug release profiles.
Ornell KJ; Lozada D; Phan NV; Coburn JM
J Mater Chem B; 2019 Apr; 7(13):2151-2161. PubMed ID: 32073574
[TBL] [Abstract][Full Text] [Related]
12. Episcleral implants for topotecan delivery to the posterior segment of the eye.
Carcaboso AM; Chiappetta DA; Opezzo JA; Höcht C; Fandiño AC; Croxatto JO; Rubio MC; Sosnik A; Abramson DH; Bramuglia GF; Chantada GL
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2126-34. PubMed ID: 19834044
[TBL] [Abstract][Full Text] [Related]
13. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
14. Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier.
Pascual-Pasto G; Olaciregui NG; Opezzo JAW; Castillo-Ecija H; Cuadrado-Vilanova M; Paco S; Rivero EM; Vila-Ubach M; Restrepo-Perdomo CA; Torrebadell M; Suñol M; Schaiquevich P; Mora J; Bramuglia GF; Chantada GL; Carcaboso AM
J Control Release; 2017 Oct; 264():34-44. PubMed ID: 28830790
[TBL] [Abstract][Full Text] [Related]
15. Water sorption dynamics of a binary copolymeric hydrogel of 2-hydroxyethyl methacrylate (HEMA).
Bajpai AK; Shrivastava M
J Biomater Sci Polym Ed; 2002; 13(3):237-56. PubMed ID: 12102592
[TBL] [Abstract][Full Text] [Related]
16. Modulated release of cyclosporine from soluble vinyl pyrrolidone--hydroxyethyl methacrylate copolymer hydrogels. A correlation of 'in vitro' and 'in vivo' experiments.
Gallardo A; Fernández F; Cifuentes A; Díez-Masa JC; Bermejo P; Rebuelta M; López-Bravo A; San Román J
J Control Release; 2001 May; 72(1-3):1-11. PubMed ID: 11389980
[TBL] [Abstract][Full Text] [Related]
17. Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels.
Kapoor Y; Chauhan A
Int J Pharm; 2008 Sep; 361(1-2):222-9. PubMed ID: 18577433
[TBL] [Abstract][Full Text] [Related]
18. Development of sustained antimicrobial-release systems using poly(2-hydroxyethyl methacrylate)/trimethylolpropane trimethacrylate hydrogels.
Kitagawa H; Takeda K; Kitagawa R; Izutani N; Miki S; Hirose N; Hayashi M; Imazato S
Acta Biomater; 2014 Oct; 10(10):4285-95. PubMed ID: 24952074
[TBL] [Abstract][Full Text] [Related]
19. Epalrestat-loaded silicone hydrogels as contact lenses to address diabetic-eye complications.
Alvarez-Rivera F; Concheiro A; Alvarez-Lorenzo C
Eur J Pharm Biopharm; 2018 Jan; 122():126-136. PubMed ID: 29079419
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting.
Raza F; Zhu Y; Chen L; You X; Zhang J; Khan A; Khan MW; Hasnat M; Zafar H; Wu J; Ge L
Biomater Sci; 2019 Apr; 7(5):2023-2036. PubMed ID: 30839983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
